In-Kyung Jeong

29PUBLICATIONS
86CO-AUTHORS
TransgenesisMajor global burdens of diseaseSouth-East Asian literature (excl. Indonesian)Cardiology (incl. cardiovascular diseases)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 15, 2026
Enavogliflozin Improves Non-invasive Hepatic Steatosis Indices in Patients With Type 2 Diabetes: A Pooled Analysis of Three Randomised Trials.

|Mar 19, 2026
Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.

Ji Eun Jun, Seohyun Kim, In-Kyung Jeong

|Feb 09, 2026
Deep Appreciation to Our Reviewers in the Past Year 2025.

Ji Hye Heo, In-Kyung Jeong

|Feb 09, 2026
A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions.

Youngwoo Jang, Jang Hoon Lee, Sang-Guk Lee

|Jan 21, 2026
A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions.

Youngwoo Jang, Jang Hoon Lee, Sang-Guk Lee

|Dec 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.

Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong

Pageof 5

Frequent Collaborators

5 joint publications

Hae Jin Kim

5 joint publications

Ji Eun Jun

4 joint publications

Byung Jin Kim

4 joint publications

You-Cheol Hwang